Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Similar presentations


Presentation on theme: "Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,"— Presentation transcript:

1 Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt, MD, Samuel R. Money, MD, Eric P. Brass, MD, PhD  Journal of Vascular Surgery  Volume 47, Issue 2, Pages e2 (February 2008) DOI: /j.jvs Copyright © 2008 The Society for Vascular Surgery Terms and Conditions

2 Fig All cause mortality ≤30 days after the last dose of drug in the on-treatment population. Journal of Vascular Surgery  , e2DOI: ( /j.jvs ) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions


Download ppt "Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,"

Similar presentations


Ads by Google